Condition (MeSH)
Myoma
ClinicalTrials.gov lists 50 trials for Myoma or a narrower condition beneath it. Acessa Health, Inc. has the most among industry and government lead sponsors, with 4.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
50 of the 50 trials are tagged with Myoma itself; the rest are tagged with a narrower condition beneath it.
When did Myoma trials start? (20)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 3 |
| 2024 | 1 |
| 2023 | 3 |
| 2022 | 3 |
| 2021 | 5 |
| 2020 | 1 |
| 2019 | 3 |
| 2018 | 2 |
| 2016 | 3 |
| 2015 | 2 |
Showing 10 of 20 earlier years.
No forecast is made for this condition: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 7 trials still running at the 2026-10-09 snapshot; registered median of 26 months across 30 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Myoma trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 2 | 1 |
| Phase 4 | 5 |
| Not applicable | 30 |
| Observational | 12 |
How many Myoma trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 7 |
| Completed | 29 |
| Terminated | 3 |
| Withdrawn | 1 |
| Unknown status | 10 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Myoma trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Acessa Health, Inc. | 4 |
| National Cancer Center, Korea | 2 |
| Angiotech Pharmaceuticals | 1 |
| BioRegen Biomedical (Changzhou) Co., Ltd | 1 |
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Terlipressinum | 3 |
| carbetocin 100 µg | 2 |
| Vasopressins | 2 |
| IM Oxytocin | 1 |
| Topical TA | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Myoma trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Chest Pain | 2 | 1 |
| Achilles tendon rupture and intervertebral disc repair | 1 | 1 |
| Anemia, resulting in blood transfusion | 1 | 1 |
| Atelactasis | 1 | 1 |
| Deep Vein Thrombus | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Myoma? (18)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma. | Gynecologic oncology | 2023 | Yes |
| Triple vs. single uterine tourniquet to reduce hemorrhage at myomectomy: a randomized trial. | Archives of gynecology and obstetrics | 2023 | Yes |
| A self-developed contained bag for laparoscopic myomectomy morcellation. | Ginekologia polska | 2022 | Yes |
| Inbag Morcellation Applied to the Laparoscopic Surgery of Leiomyoma: A Randomized Controlled Trial. | BioMed research international | 2021 | Yes |
| Office Hysteroscopic Laser Enucleation of Submucous Myomas without Mass Extraction: A Case Series Study. | BioMed research international | 2015 | Yes |
Showing 5 of 18 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.